| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-08-28 19:34:36 UTC |
|---|
| Update Date | 2021-09-26 22:48:54 UTC |
|---|
| HMDB ID | HMDB0242242 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | (+)-3,4-Didehydrocoronaridine |
|---|
| Description | (+)-3,4-Didehydrocoronaridine belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. Based on a literature review very few articles have been published on (+)-3,4-Didehydrocoronaridine. This compound has been identified in human blood as reported by (PMID: 31557052 ). (+)-3,4-didehydrocoronaridine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (+)-3,4-Didehydrocoronaridine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CCC1=CC2CN3CCC4=C(NC5=CC=CC=C45)C(C2)(C13)C(=O)OC InChI=1S/C21H24N2O2/c1-3-14-10-13-11-21(20(24)25-2)18-16(8-9-23(12-13)19(14)21)15-6-4-5-7-17(15)22-18/h4-7,10,13,19,22H,3,8-9,11-12H2,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| Catharanthine monohydrochloride, (2alpha,5beta,6alpha,18beta)-isomer | HMDB | | Catharanthine sulfate, (2alpha,5beta,6alpha,18beta)-isomer | HMDB | | Methyl 17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8,16-pentaene-1-carboxylic acid | HMDB | | Methyl 17-ethyl-3,13-diazapentacyclo[13.3.1.0,.0,.0,]nonadeca-2(10),4,6,8,16-pentaene-1-carboxylic acid | HMDB |
|
|---|
| Chemical Formula | C21H24N2O2 |
|---|
| Average Molecular Weight | 336.435 |
|---|
| Monoisotopic Molecular Weight | 336.183778021 |
|---|
| IUPAC Name | methyl 17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8,16-pentaene-1-carboxylate |
|---|
| Traditional Name | methyl 17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8,16-pentaene-1-carboxylate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCC1=CC2CN3CCC4=C(NC5=CC=CC=C45)C(C2)(C13)C(=O)OC |
|---|
| InChI Identifier | InChI=1S/C21H24N2O2/c1-3-14-10-13-11-21(20(24)25-2)18-16(8-9-23(12-13)19(14)21)15-6-4-5-7-17(15)22-18/h4-7,10,13,19,22H,3,8-9,11-12H2,1-2H3 |
|---|
| InChI Key | CMKFQVZJOWHHDV-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Ibogan-type alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Ibogan-type alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Ibogan skeleton
- Catharanthine skeleton
- Pyrroloazepine
- 3-alkylindole
- Indole
- Indole or derivatives
- Piperidinecarboxylic acid
- Azepine
- Aralkylamine
- Benzenoid
- Piperidine
- Methyl ester
- Heteroaromatic compound
- Pyrrole
- Amino acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid ester
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Amine
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 5.79 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.6747 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.36 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2009.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 226.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 177.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 174.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 143.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 452.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 421.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 327.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 902.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 462.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1337.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 304.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 312.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 302.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 189.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (+)-3,4-Didehydrocoronaridine,1TMS,isomer #1 | CCC1=CC2CN3CCC4=C(N([Si](C)(C)C)C5=CC=CC=C45)C(C(=O)OC)(C2)C13 | 2846.8 | Semi standard non polar | 33892256 | | (+)-3,4-Didehydrocoronaridine,1TMS,isomer #1 | CCC1=CC2CN3CCC4=C(N([Si](C)(C)C)C5=CC=CC=C45)C(C(=O)OC)(C2)C13 | 2716.5 | Standard non polar | 33892256 | | (+)-3,4-Didehydrocoronaridine,1TMS,isomer #1 | CCC1=CC2CN3CCC4=C(N([Si](C)(C)C)C5=CC=CC=C45)C(C(=O)OC)(C2)C13 | 3625.8 | Standard polar | 33892256 | | (+)-3,4-Didehydrocoronaridine,1TBDMS,isomer #1 | CCC1=CC2CN3CCC4=C(N([Si](C)(C)C(C)(C)C)C5=CC=CC=C45)C(C(=O)OC)(C2)C13 | 2980.0 | Semi standard non polar | 33892256 | | (+)-3,4-Didehydrocoronaridine,1TBDMS,isomer #1 | CCC1=CC2CN3CCC4=C(N([Si](C)(C)C(C)(C)C)C5=CC=CC=C45)C(C(=O)OC)(C2)C13 | 2956.4 | Standard non polar | 33892256 | | (+)-3,4-Didehydrocoronaridine,1TBDMS,isomer #1 | CCC1=CC2CN3CCC4=C(N([Si](C)(C)C(C)(C)C)C5=CC=CC=C45)C(C(=O)OC)(C2)C13 | 3715.6 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - (+)-3,4-Didehydrocoronaridine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ab9-5049000000-13385620786460b12e57 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (+)-3,4-Didehydrocoronaridine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - (+)-3,4-Didehydrocoronaridine 6V, Positive-QTOF | splash10-000f-0903000000-79b4b1d331c0726cf4c8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-3,4-Didehydrocoronaridine 10V, Positive-QTOF | splash10-000i-0009000000-1cddba253168da18a276 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-3,4-Didehydrocoronaridine 20V, Positive-QTOF | splash10-000i-0019000000-7a05aca91937e9e41118 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-3,4-Didehydrocoronaridine 40V, Positive-QTOF | splash10-0006-0900000000-2a5a9af8c219cbeae15d | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-3,4-Didehydrocoronaridine 10V, Negative-QTOF | splash10-000i-0009000000-feefd2093b1b97404034 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-3,4-Didehydrocoronaridine 20V, Negative-QTOF | splash10-000i-0009000000-11dfe5b47259e34955e8 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-3,4-Didehydrocoronaridine 40V, Negative-QTOF | splash10-004j-0090000000-77c942d1434cc90f78ec | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|